Vesicular Monoamine Transport Proteins

"Vesicular Monoamine Transport Proteins" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

A family of vesicular amine transporter proteins that catalyze the transport and storage of CATECHOLAMINES and indolamines into SECRETORY VESICLES.

Descriptor ID	D050493
MeSH Number(s)	D12.776.157.530.450.162.887.500.500 D12.776.157.530.562.750.500.500 D12.776.543.585.450.162.887.500.500 D12.776.543.585.562.750.500.500
Concept/Terms	Vesicular Monoamine Transport Proteins Vesicular Monoamine Transport Proteins Vesicular Monoamine Transporter Proteins Monoamine Vesicular Transporter Vesicular Transporter, Monoamine Vesicular Monoamine Transporter Monoamine Transporter, Vesicular Monoamine Transporters, Vesicular Vesicular Monoamine Transporters Monoamine Vesicular Transport Proteins Vesicular Monoamine Transporter 1 Vesicular Monoamine Transporter 1 VMAT-1 Vesicular Monoamine Transporter VMAT 1 Vesicular Monoamine Transporter Chromaffin Granule Amine Transporter Vesicular Monoamine Transporter 2 Vesicular Monoamine Transporter 2 VMAT2 Vesicular Monoamine Transporter

Below are MeSH descriptors whose meaning is more general than "Vesicular Monoamine Transport Proteins".

Chemicals and Drugs [D]
Amino Acids, Peptides, and Proteins [D12]
Proteins [D12.776]
Carrier Proteins [D12.776.157]
Membrane Transport Proteins [D12.776.157.530]
Ion Pumps [D12.776.157.530.450]
Antiporters [D12.776.157.530.450.162]
Vesicular Neurotransmitter Transport Proteins [D12.776.157.530.450.162.887]
Vesicular Biogenic Amine Transport Proteins [D12.776.157.530.450.162.887.500]
Vesicular Monoamine Transport Proteins [D12.776.157.530.450.162.887.500.500]
Neurotransmitter Transport Proteins [D12.776.157.530.562]
Vesicular Neurotransmitter Transport Proteins [D12.776.157.530.562.750]
Vesicular Biogenic Amine Transport Proteins [D12.776.157.530.562.750.500]
Vesicular Monoamine Transport Proteins [D12.776.157.530.562.750.500.500]
Membrane Proteins [D12.776.543]
Membrane Transport Proteins [D12.776.543.585]
Ion Pumps [D12.776.543.585.450]
Antiporters [D12.776.543.585.450.162]
Vesicular Neurotransmitter Transport Proteins [D12.776.543.585.450.162.887]
Vesicular Biogenic Amine Transport Proteins [D12.776.543.585.450.162.887.500]
Vesicular Monoamine Transport Proteins [D12.776.543.585.450.162.887.500.500]
Neurotransmitter Transport Proteins [D12.776.543.585.562]
Vesicular Neurotransmitter Transport Proteins [D12.776.543.585.562.750]
Vesicular Biogenic Amine Transport Proteins [D12.776.543.585.562.750.500]
Vesicular Monoamine Transport Proteins [D12.776.543.585.562.750.500.500]

Below are MeSH descriptors whose meaning is related to "Vesicular Monoamine Transport Proteins".

Below are MeSH descriptors whose meaning is more specific than "Vesicular Monoamine Transport Proteins".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Vesicular Monoamine Transport Proteins" by people in this website by year, and whether "Vesicular Monoamine Transport Proteins" was a major or minor topic of these publications.

Bar chart showing 10 publications over 9 distinct years, with a maximum of 2 publications in 2025

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
2000	0	1	1
2009	0	1	1
2010	1	0	1
2011	0	1	1
2013	0	1	1
2014	1	0	1
2017	0	1	1
2018	1	0	1
2025	1	1	2

Below are the most recent publications written about "Vesicular Monoamine Transport Proteins" by people in Profiles.

Garcia V, Collins SA, Hernandez E, Cruz A, Vasquez A, Sweeney AM, Perez RA, Brito BN, Morera OF, Casta?eda E. A proposed mechanism for amphetamine-induced behavioral sensitization involving the vesicular monoamine transporter. Brain Res. 2025 Oct 15; 1865:149848.

View in: PubMed
Kim S, Pajarillo E, Digman A, Ajayi I, Son DS, Aschner M, Lee E. CAD (Cath. a-Differentiated) Cells Produce Dopamine along with Dopamine-Synthesizing Enzymes. Neurochem Res. 2025 Jul 16; 50(4):233.

View in: PubMed
Liu JJ, Hezghia A, Shaikh SR, Cenido JF, Stark RE, Mann JJ, Sublette ME. Regulation of monoamine transporters and receptors by lipid microdomains: implications for depression. Neuropsychopharmacology. 2018 10; 43(11):2165-2179.

View in: PubMed
Hedges DM, Obray JD, Yorgason JT, Jang EY, Weerasekara VK, Uys JD, Bellinger FP, Steffensen SC. Methamphetamine Induces Dopamine Release in the Nucleus Accumbens Through a Sigma Receptor-Mediated Pathway. Neuropsychopharmacology. 2018 05; 43(6):1405-1414.

View in: PubMed
Grygoruk A, Chen A, Martin CA, Lawal HO, Fei H, Gutierrez G, Biedermann T, Najibi R, Hadi R, Chouhan AK, Murphy NP, Schweizer FE, Macleod GT, Maidment NT, Krantz DE. The redistribution of Drosophila vesicular monoamine transporter mutants from synaptic vesicles to large dense-core vesicles impairs amine-dependent behaviors. J Neurosci. 2014 May 14; 34(20):6924-37.

View in: PubMed
Lawal HO, Krantz DE. SLC18: Vesicular neurotransmitter transporters for monoamines and acetylcholine. Mol Aspects Med. 2013 Apr-Jun; 34(2-3):360-72.

View in: PubMed
Wang Z, Ferdousy F, Lawal H, Huang Z, Daigle JG, Izevbaye I, Doherty O, Thomas J, Stathakis DG, O'Donnell JM. Catecholamines up integrates dopamine synthesis and synaptic trafficking. J Neurochem. 2011 Dec; 119(6):1294-305.

View in: PubMed
Lawal HO, Chang HY, Terrell AN, Brooks ES, Pulido D, Simon AF, Krantz DE. The Drosophila vesicular monoamine transporter reduces pesticide-induced loss of dopaminergic neurons. Neurobiol Dis. 2010 Oct; 40(1):102-12.

View in: PubMed
Yu PL, Wu CI, Lee TS, Pan WH, Wang PS, Wang SW. Attenuation of estradiol on the reduction of striatal dopamine by amphetamine in ovariectomized rats. J Cell Biochem. 2009 Dec 15; 108(6):1318-24.

View in: PubMed
German DC, Liang CL, Manaye KF, Lane K, Sonsalla PK. Pharmacological inactivation of the vesicular monoamine transporter can enhance 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurodegeneration of midbrain dopaminergic neurons, but not locus coeruleus noradrenergic neurons. Neuroscience. 2000; 101(4):1063-9.

View in: PubMed

People

Explore

Similar Concepts

Top Journals